rs34439033

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001110556.2(FLNA):​c.4233G>A​(p.Ser1411=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000777 in 1,210,037 control chromosomes in the GnomAD database, including 7 homozygotes. There are 261 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., 72 hem., cov: 25)
Exomes 𝑓: 0.00057 ( 6 hom. 189 hem. )

Consequence

FLNA
NM_001110556.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -2.82
Variant links:
Genes affected
FLNA (HGNC:3754): (filamin A) The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant X-154359316-C-T is Benign according to our data. Variant chrX-154359316-C-T is described in ClinVar as [Benign]. Clinvar id is 129073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154359316-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.82 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00281 (317/112756) while in subpopulation AFR AF= 0.00909 (283/31120). AF 95% confidence interval is 0.00822. There are 1 homozygotes in gnomad4. There are 72 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 72 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FLNANM_001110556.2 linkuse as main transcriptc.4233G>A p.Ser1411= synonymous_variant 25/48 ENST00000369850.10 NP_001104026.1
FLNANM_001456.4 linkuse as main transcriptc.4233G>A p.Ser1411= synonymous_variant 25/47 NP_001447.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FLNAENST00000369850.10 linkuse as main transcriptc.4233G>A p.Ser1411= synonymous_variant 25/481 NM_001110556.2 ENSP00000358866 P21333-1

Frequencies

GnomAD3 genomes
AF:
0.00278
AC:
313
AN:
112706
Hom.:
1
Cov.:
25
AF XY:
0.00198
AC XY:
69
AN XY:
34846
show subpopulations
Gnomad AFR
AF:
0.00898
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000930
Gnomad ASJ
AF:
0.00526
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000169
Gnomad OTH
AF:
0.000658
GnomAD3 exomes
AF:
0.00104
AC:
189
AN:
181247
Hom.:
1
AF XY:
0.000697
AC XY:
47
AN XY:
67473
show subpopulations
Gnomad AFR exome
AF:
0.00931
Gnomad AMR exome
AF:
0.000840
Gnomad ASJ exome
AF:
0.00309
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000524
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000222
Gnomad OTH exome
AF:
0.00202
GnomAD4 exome
AF:
0.000568
AC:
623
AN:
1097281
Hom.:
6
Cov.:
33
AF XY:
0.000520
AC XY:
189
AN XY:
363191
show subpopulations
Gnomad4 AFR exome
AF:
0.00966
Gnomad4 AMR exome
AF:
0.00105
Gnomad4 ASJ exome
AF:
0.00335
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000923
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000181
Gnomad4 OTH exome
AF:
0.00206
GnomAD4 genome
AF:
0.00281
AC:
317
AN:
112756
Hom.:
1
Cov.:
25
AF XY:
0.00206
AC XY:
72
AN XY:
34906
show subpopulations
Gnomad4 AFR
AF:
0.00909
Gnomad4 AMR
AF:
0.000929
Gnomad4 ASJ
AF:
0.00526
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000169
Gnomad4 OTH
AF:
0.000651
Alfa
AF:
0.00291
Hom.:
20
Bravo
AF:
0.00314
EpiCase
AF:
0.000327
EpiControl
AF:
0.000533

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxOct 30, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 13, 2015- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 10, 2023- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMay 21, 2020- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 02, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
FLNA-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 20, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.057
DANN
Benign
0.50
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34439033; hg19: chrX-153587684; API